Demetrix Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
103
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$50M
- Investors
-
5
Demetrix General Information
Description
Developer of a fermentation system designed to create natural medicines. The company's system uses genetics and computing-enabled deciphering technology to produce co-evolved and bio-inspired cannabinoids medicines and nutraceuticals in genetics, synthetic biology, and data science, enabling physicians to understand and harvest biology into bio-inspired medicines and nutraceuticals for gene synthesis.
Contact Information
Website
www.demetrix.comCorporate Office
- 25801 Industrial Boulevard
- A-200
- Hayward, CA 94545
- United States
Corporate Office
- 25801 Industrial Boulevard
- A-200
- Hayward, CA 94545
- United States
Demetrix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 10-Feb-2021 | $50M | Completed | Generating Revenue | ||
| 2. Seed Round | 07-Jan-2019 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Demetrix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Demetrix Comparisons
Industry
Financing
Details
Demetrix Competitors (8)
One of Demetrix’s 8 competitors is GlycosBio, a Venture Capital-Backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlycosBio | Venture Capital-Backed | Houston, TX | ||||
| Renew Biopharma | Corporation | San Diego, CA | ||||
| BioMediCan | Venture Capital-Backed | Fremont, CA | ||||
| Hyasynth | Venture Capital-Backed | Montreal, Canada | ||||
| Cellibre | Venture Capital-Backed | San Diego, CA |
Demetrix Patents
Demetrix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230082130-A1 | Use of cannabinoid compounds to treat or prevent fungal growth of c. albicans | Inactive | 07-Sep-2021 | ||
| WO-2023039421-A1 | Use of cannabinoid compounds to treat or prevent fungal growth of c. albicans | Inactive | 07-Sep-2021 | ||
| WO-2023009876-A1 | Improving the stability of non-petroleum oils using cannabinoid compounds to provide antioxidative betefits | Inactive | 30-Jul-2021 | ||
| US-20230044714-A1 | Stability of non-petroleum oils using cannabinoid compounds to provide antioxidative benefits | Inactive | 30-Jul-2021 | ||
| US-20230037975-A1 | Use of cannabinoid compounds in oral care compositions to inhibit the growth of p. gingivalis | Inactive | 30-Jul-2021 | A61K8/347 |
Demetrix Signals
Demetrix Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Pandect / Berkeley Catalyst Fund | Venture Capital | Minority | ||
| Tuatara Capital | PE/Buyout | Minority | ||
| Horizons Ventures | Venture Capital | Minority | ||
| University of California, Berkeley | University |
Demetrix FAQs
-
When was Demetrix founded?
Demetrix was founded in 2017.
-
Where is Demetrix headquartered?
Demetrix is headquartered in Hayward, CA.
-
What is the size of Demetrix?
Demetrix has 103 total employees.
-
What industry is Demetrix in?
Demetrix’s primary industry is Drug Discovery.
-
Is Demetrix a private or public company?
Demetrix is a Private company.
-
What is the current valuation of Demetrix?
The current valuation of Demetrix is .
-
What is Demetrix’s current revenue?
The current revenue for Demetrix is .
-
How much funding has Demetrix raised over time?
Demetrix has raised $61M.
-
Who are Demetrix’s investors?
, Pandect / Berkeley Catalyst Fund, Tuatara Capital, Horizons Ventures, and University of California, Berkeley have invested in Demetrix.
-
Who are Demetrix’s competitors?
GlycosBio, Renew Biopharma, BioMediCan, Hyasynth, and Cellibre are some of the 8 competitors of Demetrix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process